Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab. Gonzalez CG, Stevens TW, Verstockt B, Gonzalez DJ, et al. Inflamm Bowel Dis 2024;30:1536-1545.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gonzalez CG, Stevens TW, Verstockt B, Gonzalez DJ, et al. Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab. Inflamm Bowel Dis 2024;30:1536-1545.
PMID: 38367209